Cannabinoids could treat brain tumours
02 August, 2019MGC Pharmaceuticals has announced preclinical research highlighting the positive impact of using specific cannabinoid formulations in the treatment of glioblastoma.
Natural antibiotics best at combating resistance
30 July, 2019Natural antibiotics may be more effective than their synthetic counterparts at remaining effective in the wake of antibiotic resistance — although that doesn't mean they can't be given a helping hand.
Pancreas-on-a-chip could help cystic fibrosis patients
29 July, 2019A human pancreas-on-a-chip, featuring bioengineered human pancreatic organoids, is helping scientists to identify the possible cause of cystic fibrosis-related diabetes.
Cannabis addiction can be treated with… cannabis
26 July, 2019So-called cannabinoid agonist medication could help tackle dependency on cannabis — a leading cause of drug treatment episodes in Australia.
HIV completely eliminated from mice
24 July, 2019 by Lauren DavisUsing a combination of long-acting drug treatment and gene editing, US researchers claim to have eliminated replication-competent HIV-1 DNA — the virus responsible for AIDS — from the genomes of living animals.
Heart drug could help kids with brain tumours
22 July, 2019Scientists have discovered that repurposing a heart drug could significantly increase the survival rate for children with ependymoma — a particularly aggressive type of brain tumour.
Hydrogel helps to regenerate cartilage
15 July, 2019Polyacrylate hydrogels create the support and microenvironment necessary for the growth and maintenance of cartilage cells, and could be optimal candidates for use in clinical practice.
Mass drug administration effective in scabies treatment
04 July, 2019Two years after the world's first comparative trial of mass drug administration against scabies, the infection rate remained significantly down.
Drug boosts growth in children with dwarfism
01 July, 2019Tested in a global trial, the drug regulates bone development and boosts growth rates in children with achondroplasia — the most common type of dwarfism.
New drug compound could tackle hereditary kidney disease
01 July, 2019Mironid has developed a compound to treat autosomal dominant polycystic kidney disease — a hereditary, progressive disease that affects around 12 million people worldwide.
Hypertension drug holds promise for Alzheimer's disease
26 June, 2019The blood pressure drug nilvadipine increases blood flow to the brain's memory and learning centre among people with Alzheimer's disease without affecting other parts of the brain.
Chemo-free leukaemia treatment approved by FDA
25 June, 2019A trial into the treatment of chronic lymphocytic leukaemia has been so successful that the US FDA approved the treatment for patients with the disease prior to the trial data being presented.
Vic pharma manufacturer expands operations
21 June, 2019Australian Pharmaceutical Manufacturers has opened expanded operations in the suburb of Keysborough, allowing the company to increase exports and create 44 new local jobs.
'Homing beacon' attracts chemo drugs to tumours
20 June, 2019Scientists have added a 'homing beacon' to tumours, in the form of an injectable hydrogel, that attracts chemotherapy medicines towards cancer cells while sparing their normal counterparts.
New drug candidate for active rheumatoid arthritis
17 June, 2019In a large-scale, international study, 12.5 to 20% of patients who were given the drug on a daily basis experienced so-called sustained remission — a state that is almost like being cured.
